SEARCH RESULTS FOR:

Petrochemicals & Chemicals
Brazil

German Torres

PRESIDENT, BRENNTAG ESSENTIALS LATIN AMERICA
"Our commitment is to be well prepared for macro-economic challenges such as exchange rate fluctuation and inflation while managing supply chain disruptions and price corrections."
Mining
DRC
MACIG

Xavier “Jack” de Longueville

REGIONAL DIRECTOR AFRICA, ROBINSON INTERNATIONAL GROUP
Robinson International explains conditions for its analysis and testing operations in DRC.
Mining
South Africa
MACIG

Hadley Natus

CHAIRMAN, TANTALEX LITHIUM RESOURCES CORP
Tantalex Lithium Resources updates GBR on its various projects in DRC.
Mining
Canada

Don Bubar

PRESIDENT AND CEO, AVALON ADVANCED MATERIALS INC
Avalon Advanced Materials describes how it is developing mid-stream battery material processing in Ontario.
Mining
Peru
Canada
Chile
Colombia
Ecuador

Daniel McKinnon

PRESIDENT AND CEO, MPX GEOPHYSICS
MPX Geophysics explains recent improvements in airborne technologies for geological explorations.
Petrochemicals & Chemicals
Singapore

Nikunj Parekh

FOUNDER AND CEO, KEMPAR ENERGY
Kempar Energy speaks to GBR about its trading operations.
Petrochemicals & Chemicals
Singapore

Laura Ashton

MANAGING DIRECTOR, LOW CARBON ADVISORS (LCA)
Low Carbon Advisors is a global advisory firm providing Board-level advice on decarbonisation and sustainability.
Mining
Ghana
MACIG

Richard Ansong

PARTNER, PWC GHANA
PwC Ghana updates GBR on the countries financial and regulatory conditions.
Mining
Zambia
MACIG

Pierre Léveillé

PRESIDENT & CEO, DEEP SOUTH RESOURCES
Deep South Resources remains determined to mine its Haib copper project in Namibia.
Mining
Chile

Juan Andrés Méndez

GENERAL MANAGER – ENERGY SOLUTIONS, GASCO
Gasco explains how it is offering more sustainable energy to Chile’s mines.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL